Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zuoli Pharmaceutical is a prominent Chinese pharmaceutical company focused on the development of medicinal fungi-based therapies. The company is best known for its proprietary Wuling Capsule, a Traditional Chinese Medicine (TCM) derived from Xylaria nigripes, used extensively for insomnia and psychological distress. Its product portfolio also includes Bailing Tablets for renal and respiratory health and Lingze Tablets for urological conditions. Zuoli leverages advanced fermentation technology to produce high-quality medicinal fungi at scale. Publicly traded on the Shenzhen Stock Exchange, the company continues to expand its presence in the mental health and chronic disease management sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Zuoli.